Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.01
+0.81 (7.23%)
At close: May 1, 2026, 4:00 PM EDT
11.96
-0.05 (-0.42%)
After-hours: May 1, 2026, 7:55 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $953.96 million as of May 1, 2026. Its market cap has increased by 224.24% in one year.
Market Cap
953.96M
Enterprise Value
1.41B
1-Year Change
224.24%
Ranking
Category
Stock Price
$12.01
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $953.96M, an increase of 80.97%. That is a compound annual growth rate of 9.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 953.96M | -19.17% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.01B |
| ORIC Pharmaceuticals | 980.50M |
| Maravai LifeSciences Holdings | 958.86M |
| Annexon | 934.42M |
| Xencor | 930.67M |
| CytomX Therapeutics | 909.96M |
| SELLAS Life Sciences Group | 909.75M |
| LB Pharmaceuticals | 901.28M |